Technical Analysis for TMDX - TransMedics Group, Inc.

Grade Last Price % Change Price Change
F 77.20 -6.90% -5.72
TMDX closed down 6.9 percent on Wednesday, November 20, 2024, on 1.71 times normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
4 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down

Date Alert Name Type % Chg
Death Cross Bearish 0.00%
Multiple of Ten Bearish Other 0.00%
Wide Bands Range Expansion 0.00%
Gapped Down Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Slingshot Bearish Bearish Swing Setup -6.90%
NR7 Range Contraction -6.90%
Narrow Range Bar Range Contraction -6.90%
Wide Bands Range Expansion -6.90%
Oversold Stochastic Weakness -6.90%

   Recent Intraday Alerts

Alert Time
Down 1 ATR about 23 hours ago
3x Volume Pace about 23 hours ago
2x Volume Pace about 23 hours ago
1.5x Volume Pace about 23 hours ago
Down 5% about 23 hours ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

TransMedics Group, Inc. Description

TransMedics, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. The company offers Organ Care System (OCS), an integrated, compact, portable preservation technology that addresses unmet need for organs for transplantation. Its Organ Care System preserve organ quality, assess organ viability prior to transplant, and potentially increase the utilization of donor organs for the treatment of end-stage heart, lung, and liver failure. Its Organ Care System incudes OCS LUNG, a portable perfusion, ventilation, and monitoring system that maintains organs in a near physiologic state and enables surgeons to perfuse and ventilate the organ between the donor and recipient sites; OCS Heart, a portable heart perfusion system that helps to maintain organs in a warm functioning state outside of the body; and OCS Liver, a portable perfusion and monitoring system that maintains organs in a near physiologic state. The company offers its products in the United States and internationally. TransMedics, Inc. is headquartered in Andover, Massachusetts. TransMedics, Inc. is a subsidiary of Transmedics Group, Inc.


Classification

Sector: Healthcare
Industry: Medical Devices
Keywords: Medicine Disease Surgery Medical Technology Transplantation Perfusion Organs Transplantation Medicine Organ Failure Organ Transplantation Organ Transplant

Is TMDX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 177.37
52 Week Low 67.7693
Average Volume 1,708,657
200-Day Moving Average 122.27
50-Day Moving Average 122.08
20-Day Moving Average 90.86
10-Day Moving Average 85.46
Average True Range 6.52
RSI (14) 27.54
ADX 38.06
+DI 18.91
-DI 43.57
Chandelier Exit (Long, 3 ATRs) 114.64
Chandelier Exit (Short, 3 ATRs) 95.17
Upper Bollinger Bands 120.09
Lower Bollinger Band 61.62
Percent B (%b) 0.27
BandWidth 64.35
MACD Line -11.69
MACD Signal Line -12.53
MACD Histogram 0.8391
Fundamentals Value
Market Cap 2.52 Billion
Num Shares 32.6 Million
EPS -1.09
Price-to-Earnings (P/E) Ratio -70.83
Price-to-Sales 15.17
Price-to-Book 22.90
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 85.43
Resistance 3 (R3) 85.81 83.45 84.06
Resistance 2 (R2) 83.45 81.35 83.26 83.60
Resistance 1 (R1) 80.33 80.06 79.15 79.94 83.14
Pivot Point 77.97 77.97 77.38 77.77 77.97
Support 1 (S1) 74.84 75.87 73.66 74.46 71.26
Support 2 (S2) 72.48 74.58 72.29 70.80
Support 3 (S3) 69.36 72.48 70.34
Support 4 (S4) 68.97